Diagnostic and Therapeutic Challenges in Statin‐Induced Necrotizing Autoimmune Myopathy in an Elderly Patient: A Rare Case Report [PDF]
Clinical Case ReportsWe present the case of a 78‐year‐old woman with metabolic syndrome and a history of multiple ischemic strokes who developed progressive symmetrical proximal muscle weakness, predominantly affecting the lower extremities, while on atorvastatin. Laboratory
Nischal Shrestha +2 more
doaj +3 more sources
Clinical Images: Tissue remodeling in autoimmune statin‐induced necrotizing autoimmune myopathy [PDF]
ACR Open Rheumatology, 2022 Larissa Valor‐Méndez +5 more
doaj +4 more sources
A Case Series of Statin-Induced Necrotizing Autoimmune Myopathy [PDF]
Cureus, 2022 The use of statins has been increasing over the past decade for the primary and secondary prevention of cardiovascular disease worldwide. Subsequently, various side effects have also been unfolding. Muscle-related side effects secondary to statins range from myalgia to rhabdomyolysis and need close monitoring for early detection.
Sharma, Alisha +4 more
openaire +3 more sources
Statin-induced necrotizing autoimmune myopathy: An uncommon complication of a commonly used medication [PDF]
Journal of the Saudi Heart Association, 2019 A well-known side effect of statin therapy is myopathy. We report a case of statin induced necrotizing autoimmune myopathy, a rare variant of statin-induced myopathy. A 64-year-old gentleman on atorvastatin presented with muscle weakness.
Yehia Saleh +3 more
doaj +2 more sources
A Rare Case of Statin-Induced Necrotizing Autoimmune Myopathy [PDF]
AACE Clinical Case Reports, 2020 Necrotizing autoimmune myopathy (NAM) is a rare side-effect of statin therapy. We report the case of a patient who developed statin-induced NAM with a review of the clinical presentation and management of this rare entity. The case illustrates the importance of including NAM in the differential diagnosis of persistent myopathy in a statin-exposed ...
Shirley Shuster, MD +1 more
openaire +4 more sources
Severe Anti-HMG-CoAR Necrotizing Autoimmune Myopathy Secondary to Statin Use [PDF]
Case Reports in Rheumatology, 2022 Immune-mediated necrotizing myopathy is an uncommon but debilitating disease that can be triggered by drugs, toxins, or cancer. It is similar to polymyositis in presentation but is differentiated by findings on muscle biopsy.
Priyanjali Pulipati +2 more
doaj +2 more sources
A Case of Statin-Induced Necrotizing Autoimmune Myopathy [PDF]
CureusStatins, commonly used for hyperlipidemia and more importantly having proven efficacy in lowering cardiovascular risk, are a very popular class of medications. Side effects are usually mild, and the class as a whole is generally well-tolerated by patients. However, one rare and more serious side effect is statin-induced autoimmune necrotizing myopathy.
Desai, Inshya +2 more
openaire +3 more sources
Necrotizing Autoimmune Myopathy: A Case Report on Statin-Induced Rhabdomyolysis [PDF]
Cureus, 2023 Statin-induced necrotizing myopathy (SINM) is an uncommon but severe complication associated with statin medication. SINM can develop at any point after a person starts taking steroids. It is now being acknowledged as a component of the broader category of "statin-induced myopathy." Like other immune-mediated necrotizing muscle diseases, statin-induced
Altaf, Faryal +6 more
openaire +3 more sources
Evidence of Cardiac Involvement in a Patient With Necrotizing Autoimmune Myopathy (NAM) [PDF]
Cureus, 2023 Necrotizing autoimmune myopathy (NAM) is a rare inflammatory myopathy primarily affecting skeletal muscles. Cardiac involvement has been reported in immune-mediated necrotizing myopathy (IMNM), but its extent remains poorly understood. We present a unique case of a 68-year-old male with anti-signal recognition particle (SRP) antibody-positive NAM ...
Khan, Omair A +4 more
openaire +3 more sources
Statin-Induced Necrotizing Autoimmune Myopathy: Case Report of a Patient under Chronic Treatment [PDF]
Case Reports in Medicine, 2023 Introduction. 3-Hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors are widely used worldwide to treat dyslipidaemia and prevent cardiovascular events.
Ilaria Anna Bellofatto +16 more
doaj +2 more sources